Production (Stage)
ProMIS Neurosciences, Inc.
PMN
$0.5083
$0.02755.72%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.35M | -238.20K | 9.28M | -2.62M | -3.64M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 245.30K | -4.91M | -13.35M | -41.10K | 77.70K |
| Change in Net Operating Assets | 2.18M | -3.56M | -2.59M | 1.16M | -6.73M |
| Cash from Operations | -4.93M | -8.72M | -6.67M | -1.50M | -10.29M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -700.00 | -- | -- | -- |
| Cash from Investing | -- | -700.00 | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 470.00K | 27.22M | 0.00 | 190.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 470.00K | 27.22M | 0.00 | 190.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.93M | -8.25M | 20.54M | -1.50M | -10.10M |